Mercy Health - Clermont Hospital LLC

Mercy Health - Clermont Hospital LLC was paid $25.87M by Medicaid between Jan 2018 and Dec 2024, across 291 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.

33Billing provider infoMERCY HEALTH - CLERMONT HOSPITAL LLC
BATAVIA, OH 45103

33aNPI1568562551assigned 09/22/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$25.87M

24GClaims709,186

24DCodes billed291

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#46 of 101

Median peer was paid$22.32M

This provider vs. median1.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	78,879	$2.84M
2019	63,517	$2.45M
2020	51,876	$2.21M
2021	54,651	$2.30M
2022	67,779	$2.61M
2023	227,851	$7.79M
2024incomplete	164,633	$5.67M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	23%	49,276	46,180	$5.90M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	18%	36,088	32,851	$4.59M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	13%	24,066	21,073	$3.24M
96361	Intravenous infusion, hydration; each additional hour	6.1%	6,989	5,719	$1.57M
74177	Computed tomography, abdomen and pelvis; with contrast material	5.0%	5,059	4,299	$1.30M
70450	Computed tomography, head or brain; without contrast material	4.1%	4,668	4,000	$1.07M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.8%	13,709	3,966	$733K
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.5%	6,335	6,062	$641K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.7%	3,950	2,812	$445K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	1.5%	1,754	1,055	$395K
74176	Computed tomography, abdomen and pelvis; without contrast material	1.5%	1,544	1,281	$391K
80053	Comprehensive metabolic panel	1.4%	53,432	46,973	$372K

279 more codes

97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	1.4%	7,389	$355K
G0378	Hospital observation service, per hour	1.2%	4,859	$314K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	1,768	$233K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,129	$216K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	2,838	$176K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	414	$167K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,431	$158K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	374	$150K
95813		<1%	222	$148K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	7,977	$138K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	622	$133K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	1,211	$126K
70496		<1%	606	$119K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	961	$117K
29581		<1%	1,522	$114K
97597		<1%	1,924	$106K
71250		<1%	1,170	$101K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,060	$100K
76642		<1%	741	$91K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	6,448	$90K
71046	Radiologic examination, chest; 2 views	<1%	9,044	$84K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	513	$84K
71271		<1%	545	$80K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	5,500	$72K
97161		<1%	1,781	$59K
84484		<1%	19,153	$58K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	58,811	$56K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,927	$56K
97016		<1%	1,857	$55K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	100	$53K
G0382	Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	605	$52K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	1,100	$52K
70491		<1%	165	$49K
12001		<1%	319	$49K
93017		<1%	514	$42K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	262	$37K
H2020	Therapeutic behavioral services, per diem	<1%	273	$37K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	22,970	$35K
74018		<1%	810	$33K
71045	Radiologic examination, chest; single view	<1%	11,621	$31K
72100		<1%	739	$29K
76536		<1%	255	$26K
36415	Collection of venous blood by venipuncture	<1%	38,175	$25K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	156	$24K
80061	Lipid panel	<1%	1,401	$24K
80048	Basic metabolic panel (calcium, ionized)	<1%	4,460	$23K
84443	Thyroid stimulating hormone (TSH)	<1%	1,810	$22K
77065	Tomosynthesis, mammo	<1%	528	$18K
77066	Tomosynthesis, mammo	<1%	540	$18K
93798		<1%	330	$17K
73630		<1%	1,334	$15K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,098	$15K
94618		<1%	189	$15K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	750	$14K
73030		<1%	972	$14K
70486		<1%	266	$13K
87522	Neg quan hep c or qual rna	<1%	292	$13K
86900		<1%	882	$13K
85610		<1%	4,028	$13K
80069		<1%	735	$13K
80320		<1%	813	$12K
73610		<1%	1,200	$12K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,065	$12K
73560		<1%	605	$12K
94060		<1%	418	$12K
94726		<1%	547	$12K
93975		<1%	157	$12K
93971		<1%	146	$12K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,367	$12K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	6,910	$12K
83605		<1%	6,201	$11K
90715		<1%	806	$11K
73130		<1%	1,063	$11K
73562		<1%	679	$11K
76830	Ultrasound, transvaginal	<1%	416	$10K
64721		<1%	13	$10K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	19,029	$10K
96375	Therapeutic injection; each additional sequential IV push	<1%	12,507	$10K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	757	$10K
72131		<1%	176	$10K
83690		<1%	11,881	$10K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	959	$10K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	14	$10K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	208	$9K
86140		<1%	1,001	$9K
84703		<1%	15,951	$9K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	42	$9K
76770		<1%	69	$9K
97116		<1%	299	$8K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	4,190	$8K
84439		<1%	519	$8K
73502		<1%	444	$8K
80076		<1%	1,025	$8K
81001		<1%	17,887	$7K
12002		<1%	43	$7K
82607		<1%	492	$7K
83880		<1%	3,226	$7K
94729		<1%	582	$7K
73110		<1%	800	$7K
12011		<1%	40	$7K
87086	Culture, bacterial; quantitative colony count, urine	<1%	3,605	$6K
82077		<1%	3,430	$6K
72040		<1%	148	$6K
74174		<1%	30	$6K
82565		<1%	801	$6K
70498		<1%	587	$6K
83735		<1%	4,790	$6K
87506		<1%	78	$6K
96368		<1%	203	$6K
10060		<1%	35	$6K
85027		<1%	1,456	$6K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	873	$6K
96367		<1%	728	$5K
83550		<1%	500	$5K
86850		<1%	718	$5K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	29	$5K
80074		<1%	248	$5K
82728		<1%	373	$5K
36430		<1%	55	$5K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	11,682	$5K
86701		<1%	131	$4K
76870		<1%	56	$4K
97162		<1%	226	$4K
83970		<1%	139	$4K
73140		<1%	322	$4K
81003		<1%	8,965	$4K
83540		<1%	518	$4K
73080		<1%	385	$4K
82570		<1%	426	$3K
85652		<1%	874	$3K
73590		<1%	369	$3K
80329		<1%	446	$3K
84702		<1%	609	$3K
96376		<1%	1,981	$3K
87040		<1%	2,308	$3K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	310	$3K
83516		<1%	109	$3K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	858	$3K
97535	Self-care/home management training, each 15 minutes	<1%	106	$3K
17250		<1%	129	$3K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	901	$3K
71101		<1%	169	$3K
87390		<1%	126	$2K
87081		<1%	3,344	$2K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	14	$2K
86702		<1%	128	$2K
80143		<1%	1,913	$2K
85379		<1%	1,855	$2K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	44	$2K
97166		<1%	55	$2K
82746		<1%	384	$2K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	2,379	$2K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	12	$2K
00731		<1%	295	$2K
72141		<1%	12	$2K
76801		<1%	17	$2K
87324		<1%	140	$1K
86706		<1%	59	$1K
85730		<1%	709	$1K
82803		<1%	2,515	$1K
82784		<1%	70	$1K
86901		<1%	881	$1K
93970		<1%	13	$1K
80179		<1%	1,862	$1K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	4,254	$1K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	56	$1K
84156		<1%	232	$1K
97165		<1%	13	$1K
87186		<1%	1,059	$990.17
87077		<1%	1,204	$943.16
87449		<1%	193	$898.89
82550		<1%	567	$892.28
87210		<1%	603	$883.03
72070		<1%	20	$880.57
87340		<1%	47	$862.70
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	14	$855.74
73090		<1%	208	$799.95
87070		<1%	558	$782.61
J1650	Injection, enoxaparin sodium, 10 mg	<1%	1,695	$747.43
97014		<1%	22	$721.41
84520		<1%	94	$658.07
82105		<1%	70	$608.71
84145		<1%	816	$589.09
86480		<1%	13	$583.91
83013		<1%	14	$562.51
86038		<1%	35	$541.75
87336		<1%	57	$530.45
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	11,212	$522.14
87328		<1%	57	$472.79
J1170	Injection, hydromorphone, up to 4 mg	<1%	1,505	$459.78
84550		<1%	103	$433.56
87205		<1%	559	$433.06
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,542	$407.38
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	10,184	$387.41
87807		<1%	369	$271.19
J1953	Injection, levetiracetam, 10 mg	<1%	24	$269.13
82785		<1%	19	$264.19
82103		<1%	14	$254.97
87088		<1%	191	$216.05
82653		<1%	17	$206.18
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	124	$204.24
86803		<1%	15	$198.06
82140		<1%	108	$196.20
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	10,220	$192.60
J7030	Infusion, normal saline solution , 1000 cc	<1%	2,499	$182.71
J0780	Injection, prochlorperazine, up to 10 mg	<1%	506	$164.44
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,578	$145.63
00910		<1%	60	$128.72
J2704	Injection, propofol, 10 mg	<1%	4,840	$126.00
82043		<1%	18	$111.95
J3370	Injection, vancomycin hcl, 500 mg	<1%	643	$107.90
84100		<1%	67	$104.83
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	243	$104.10
85048		<1%	13	$99.77
83993		<1%	19	$99.51
85018		<1%	97	$95.71
J1644	Injection, heparin sodium, per 1000 units	<1%	700	$93.89
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	17	$84.40
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	2,241	$82.86
85014		<1%	65	$79.29
J2785	Injection, regadenoson, 0.1 mg	<1%	256	$73.51
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,176	$72.37
88304		<1%	439	$70.02
82270		<1%	156	$68.14
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	720	$67.73
J2060	Injection, lorazepam, 2 mg	<1%	743	$63.01
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	2,585	$62.09
J3475	Injection, magnesium sulfate, per 500 mg	<1%	643	$55.25
J1790	Injection, droperidol, up to 5 mg	<1%	420	$54.69
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	277	$53.36
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	47	$51.64
J3490	Unclassified drugs	<1%	46	$47.65
J0690	Injection, cefazolin sodium, 500 mg	<1%	974	$44.83
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	846	$39.50
84450		<1%	15	$39.03
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	415	$35.10
J7120	Ringers lactate infusion, up to 1000 cc	<1%	543	$31.68
J7050	Infusion, normal saline solution, 250 cc	<1%	275	$30.82
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	169	$30.18
J2470	Injection, pantoprazole sodium, 40 mg	<1%	95	$26.75
84460		<1%	13	$26.00
84132		<1%	121	$25.85
94761		<1%	735	$20.52
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	<1%	562	$18.82
C1769	Guide wire	<1%	59	$16.94
J3480	Injection, potassium chloride, per 2 meq	<1%	210	$14.62
J1171	Injection, hydromorphone, 0.1 mg	<1%	90	$13.75
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	<1%	328	$11.70
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	461	$11.66
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	31	$9.50
82010		<1%	95	$8.01
J1630	Injection, haloperidol, up to 5 mg	<1%	33	$6.75
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	1,491	$5.63
J1940	Injection, furosemide, up to 20 mg	<1%	37	$3.68
J8540	Dexamethasone, oral, 0.25 mg	<1%	28	$1.97
J0456	Injection, azithromycin, 500 mg	<1%	38	$1.79
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	382	$0.12
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	34	$0.00
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	0%	637	$0.00
A4648	Tissue marker, implantable, any type, each	0%	42	$0.00
88342		0%	156	$0.00
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	0%	15	$0.00
94760		0%	75	$0.00
C1819	Surgical tissue localization and excision device (implantable)	0%	39	$0.00
00790		0%	15	$0.00
C9399	Unclassified drugs or biologicals	0%	16	$0.00
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	14	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	35	$0.00
82150		0%	19	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	14	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	13	$0.00
29125		0%	136	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	72	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	63	$0.00
01810		0%	46	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	12	$0.00
00811		0%	13	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	12	$0.00
00812		0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPRESTRIDGE, TIMOTHY (PRESIDENT MH CLERMONT)